Claudia Frey Mar 24 Cytosurge’s FluidFM Technology Facilitates Multiplex CRISPR Editing and Monoclonal Cell Line Development in less than Three Weeks by Claudia Frey | March 24, 2021 4896 Zurich | Cytosurge , a leading global provider for precision single cell manipulation , announced today that its pioneering, patented FluidFM nano-probe enabled CRISPR multiplexing to generate monoclo... Read more > Press Release Corporate FluidFM Applications Mar 24, 2021 Press Release
Paul Monnier Mar 08 FluidFM: A new approach to CRISPR gene editing by Paul Monnier | March 8, 2021 5279 With traditional delivery methods, such as lipofection or electroporation, the success of CRISPR-Cas mediated gene editing is often subpar due to poor cell viability and low transfection efficiency ra... Read more > Company Blog FluidFM Applications Mar 8, 2021 Company Blog
Claudia Frey Oct 01 Novel Approaches to Overcome CRISPR In Vitro Delivery Challenges by Claudia Frey | October 1, 2020 3218 EBR October 2020 | In order for CRISPR gene editing to reach its full potential, we must develop in vitro delivery approaches that will allow us to work with hard-to-transfect cells, large repair temp... Read more > Press Clipping FluidFM Applications Oct 1, 2020 Press Clipping
Claudia Frey Jul 23 Olympus and Cytosurge collaborate to deliver a complete single-cell and CRISPR genetic manipulation solution in the Americas by Claudia Frey | July 23, 2020 5786 Waltham, Mass. & Zurich | Olympus , a leading manufacturer of high-end research microscopes, and Cytosurge , a precision manufacturer of cell manipulation technologies, have entered a co-marketing agr... Read more > Press Release Corporate Jul 23, 2020 Press Release
Claudia Frey May 04 Harvard's Wyss Institute joins forces with Cytosurge to improve CRISPR-based multiplexed gene editing by Claudia Frey | May 4, 2020 6941 Boston & Zurich | By Benjamin Boettner | Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Cytosurge AG , a company manufacturing unique high-precision nanotech... Read more > Press Release Corporate FluidFM Applications May 4, 2020 Press Release
Pascal Behr Dec 19 10 Years Cytosurge by Pascal Behr | December 19, 2019 7145 “It all started with an idea, a great environment and two scientists dreaming of becoming their own bosses.” If I had to describe to you in one sentence, why Cytosurge was founded, this would probably... Read more > Company Blog Company Life Corporate Dec 19, 2019 Company Blog
Claudia Frey Sep 02 How the FluidFM ADD-ON brings even more "Bio" into BioAFMs by Claudia Frey | September 2, 2019 22022 Would you like to unlock unique biological applications for your AFM? Are you interested in single-cell experiments? Then FluidFM might be the right technology to help you with your research. Fluidic ... Read more > Company Blog FluidFM Applications Sep 2, 2019 Company Blog
Claudia Frey Jul 09 Partnership between Olympus Europe & Cytosurge by Claudia Frey | July 9, 2019 6254 Zurich & Hamburg | Olympus Europe and Cytosurge have partnered in order to accelerate common innovation of next-generation tools for single cell experiments and to expand the distribution of the versa... Read more > Press Release Corporate Jul 9, 2019 Press Release
Claudia Frey Feb 07 FluidFM Conference 2019 by Claudia Frey | February 7, 2019 3021 The first FluidFM User Conference organized by Cytosurge has been a complete success – this was the feedback of our attendees. From Thursday, 31st January, to Friday, 1st February 2019, more than 50 F... Read more > Company Blog FluidFM People Feb 7, 2019 Company Blog
Claudia Frey Jun 29 Premium Partnership between Bruker & Cytosurge by Claudia Frey | June 29, 2018 4534 Zurich | Cytosurge AG, a Swiss company that develops, manufactures and distributes scientific high-precision nanotechnology instruments and robotic systems based on its patented FluidFM® technology, a... Read more > Press Release Corporate Jun 29, 2018 Press Release
Claudia Frey Apr 05 Success stories: Searching for a distribution partner in Germany by Claudia Frey | April 5, 2018 1765 S-GE | With its FluidFM® technology, Glattbrugg-based Cytosurge AG produces measuring and micromanipulation instruments for cutting-edge nanotechnology research: Swiss quality products, which should a... Read more > Press Clipping Corporate Apr 5, 2018 Press Clipping
Claudia Frey Feb 02 Growing interest in Cytosurge’s FluidFM technology by Claudia Frey | February 2, 2018 1357 startupticker.ch | With the launch of their patented FluidFM technology for single cell analysis, Cytosurge opened up a new frontier in biological research. Different companies have already integrated... Read more > Press Clipping Corporate Feb 2, 2018 Press Clipping
